iSiP Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.49M
- Investors
-
3
iSiP General Information
Description
Developer of artificial intelligence drug discovery technology intended for pharmaceutical research and development purposes. The company's platform integrates high-performance computing, physical simulation, and machine learning to generate novel small molecule hit compounds without the need for extensive training data or existing compound information, enabling the global healthcare sector to accelerate the identification of high-value drug candidates with greater efficiency and reduced costs.
Contact Information
Website
corp-isip.comCorporate Office
- 3 Shibuya, Shibuya-ward
- Tokyo, Bunkyo-ku
- Japan
Corporate Office
- 3 Shibuya, Shibuya-ward
- Tokyo, Bunkyo-ku
- Japan
iSiP Timeline
iSiP Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 22-May-2025 | $4.49M | Completed | Generating Revenue | ||
| 1. Seed Round | 22-Aug-2023 | Completed | Generating Revenue |
iSiP Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A Preferred | ||||||||
| S Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
iSiP Patents
iSiP Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026038558-A1 | Gpr17 inhibitor and uses thereof | Pending | 14-Aug-2024 |
iSiP Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DNX Ventures | Venture Capital | Minority | ||
| D3 (Tokyo) | Venture Capital | Minority | ||
| DEEPCORE | Venture Capital | Minority |
iSiP FAQs
-
When was iSiP founded?
iSiP was founded in 2022.
-
Where is iSiP headquartered?
iSiP is headquartered in Tokyo, Japan.
-
What industry is iSiP in?
iSiP’s primary industry is Discovery Tools (Healthcare).
-
Is iSiP a private or public company?
iSiP is a Private company.
-
What is the current valuation of iSiP?
The current valuation of iSiP is .
-
What is iSiP’s current revenue?
The current revenue for iSiP is .
-
How much funding has iSiP raised over time?
iSiP has raised $6.1M.
-
Who are iSiP’s investors?
DNX Ventures, D3 (Tokyo), and DEEPCORE have invested in iSiP.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process